DPI-221
DPI-221 is a synthetic opioid drug that acts as a highly selective agonist for the δ-opioid receptor. It was developed for its potential use in treating conditions such as pain, depression, and anxiety.
Pharmacology
DPI-221 is known for its high selectivity towards the δ-opioid receptor, which distinguishes it from other opioids that typically target the μ-opioid receptor. This selectivity is significant because δ-opioid receptor agonists are believed to produce fewer side effects compared to μ-opioid receptor agonists, such as reduced risk of respiratory depression and addiction.
Mechanism of Action
DPI-221 binds to and activates the δ-opioid receptor, which is a G protein-coupled receptor (GPCR). Activation of this receptor leads to a cascade of intracellular events that result in the modulation of neurotransmitter release and ultimately produce analgesic and mood-enhancing effects.
Potential Therapeutic Uses
Pain Management
Due to its analgesic properties, DPI-221 has been studied for its potential use in managing various types of pain, including chronic pain and neuropathic pain. Its selective action on the δ-opioid receptor may offer pain relief with a lower risk of side effects commonly associated with traditional opioids.
Depression and Anxiety
Research has indicated that δ-opioid receptor agonists like DPI-221 may have antidepressant and anxiolytic effects. This makes DPI-221 a candidate for the treatment of major depressive disorder and generalized anxiety disorder.
Side Effects and Safety
While DPI-221 is designed to minimize the side effects associated with traditional opioids, it is not entirely free from adverse effects. Common side effects may include nausea, dizziness, and headache. Long-term safety and efficacy studies are required to fully understand the risk profile of DPI-221.
Research and Development
DPI-221 is still under investigation, and its clinical applications are yet to be fully realized. Ongoing research aims to better understand its pharmacokinetics, pharmacodynamics, and potential therapeutic benefits.
See Also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD